Anthera Pharmaceuticals, Inc.
ANTH · OTC
12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $2,196 | $20,843 | $46,951 | $2,639 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $326 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $995 | $1,865 | $585 | $0 |
| Total Curr. Assets | $3,191 | $22,708 | $47,862 | $3,022 |
| Property Plant & Equip (Net) | $482 | $763 | $263 | $468 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $482 | $763 | $263 | $468 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $3,673 | $23,471 | $48,125 | $3,490 |
| Liabilities | – | – | – | – |
| Payables | $1,832 | $4,782 | $5,259 | $2,232 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $138 | $0 |
| Other Curr. Liab. | $0 | $0 | $1,475 | $2,450 |
| Total Curr. Liab. | $4,711 | $10,624 | $8,468 | $5,751 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $4,457 | $0 | $0 | $0 |
| Total NC Liab. | $4,457 | $377 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $9,168 | $11,001 | $8,468 | $5,751 |
| Equity | – | – | – | – |
| Pref Stock | $333 | $8,614 | $0 | $0 |
| Common Stock | $14 | $6 | $40 | $23 |
| Retained Earnings | -$434,428 | -$407,554 | -$352,031 | -$316,811 |
| AOCI | -$14 | -$6 | $0 | $0 |
| Other Equity | $14 | $0 | $0 | $0 |
| Total Equity | -$5,495 | $12,470 | $39,657 | -$2,261 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $3,673 | $23,471 | $48,125 | $3,490 |
| Net Debt | -$2,196 | -$20,843 | -$46,951 | -$2,639 |